The Valley Desk

ReviewDrugsPublished

Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source

Publication record

Type
Review
Venue
Drugs
Published
Subject terms
T-Lymphocytes; Humans; Dependovirus; Injections; Genetic Vectors; Antibodies, Neutralizing; Genetic Therapy; Immunosuppression Therapy
PubMed ID
36715794
Added to directory
Source checked

Report a correction or request removal